After careful consideration the ICIS and Seattle 2020 meeting leadership have decided to make Cytokines 2020 an all Virtual Meeting. This difficult decision is based upon the uncertainty of SARS-CoV-2 exposure outcome from holding an in-person gathering in Seattle.
The pandemic underscores the importance of this meeting and our research to understand cytokine and interferon biology in human health and disease. Our past and current efforts to understand the host response to viruses and other pathogens and the importance of IFN and cytokines in controlling infection and the immune response to vaccines could not be more important than it is now. Therefore we are going forward with a Virtual Meeting so as not to hinder the research in the field of cytokines and interferons, as well as the unprecedented new research dedicated to COVID-19 since the outbreak began.
The Virtual meeting will run for the original four days, 1-4 November, 2020, with 3-4 hours of live streaming per day, and on-demand view available for at least a year. This virtual learning experience brings the meeting content to the attendees and will offer live plenary sessions, symposium sessions, e-poster sessions and oral presentations, industry symposia, engagement platforms and more.
The Scientific Committee is currently reshaping the program to include the latest findings on COVID-19, making this year’s meeting highly relevant and engaging in the current medical and scientific landscape. The objective of the 8th Annual Meeting of the International Cytokine & Interferon Society is to promote interactions between scientists performing cutting-edge studies of the molecular mechanisms of cytokine and interferon function, signal transduction, and gene expression in the context of health and disease. Working with the scientific advisory committee composed of leading investigators from academia and industry, an outstanding scientific program is planned.
The Cytokines annual meeting has become the world’s most important annual conference on basic, clinical and translational research on cytokines and their roles in host defense, inflammation, tissue repair and cancer.
This meeting will explore the application of molecular and systems biology approaches to understand the mechanisms of cytokine functions in the broad areas of signal transduction, gene expression, and systems responses in the context of health and disease. In recent years, research presented at this meeting has had practical application to a wide range of clinical areas: cancer, infectious disease, inflammation, autoimmune disease, metabolism, microbiome health, and development.
Sessions will include cutting edge and basic and clinical presentations, Keynote Lectures from four world leaders in cytokine and interferon research, with 2 timely poster sessions, and a total of 55 presentations by invited speakers as well as oral abstract presentations. Attendees from all career stages will participate in 4 ground-breaking Plenary and 14 highly relevant scientific sessions (see attached schedule).
Meeting topics will include:
- SARS-CoV-2 or COVID-19
- cytokine regulation
- systems biology
- innate immunity
- cytokines in allergy and inflammation
- immune regulation
- cytokines in skin inflammatory diseases
- mucosal immunity
- autoinflammation and autoimmunity
- anti-cytokine therapy
- cytokines in HIV cure
- T cell differentiation and function
- cytokines in cancer development and antitumor immune therapy
- cytokines in microbiome interactions and interferon actions
The Organizing and International Advisory Committee is planning an outstanding scientific program. We have confirmed the following globally recognized scientists to give keynote presentations:
- Dr. Judi Allen, University of Manchester, Manchester, UK
- Dr. Michael Diamond, Washington University, St. Louis, USA
- Dr. Lalita Ramakrishnan, University of Cambridge, Cambridge, UK
- Dr. Ellen Rothenberg- Caltech, Pasadena, USA
We believe Cytokines 2020 will be a fantastic meeting and hope you will be able to participate to help make the meeting a huge success.
We look forward to welcoming you to the Cytokines 2020 Virtual Meeting!
Michael Gale, Jr., PhD Ram Savan, PhD
Department of Immunology, University of Washington School of Medicine, Seattle, WA USA
Local Organizing Committee:
Sarah L. Gaffen, PhD, Pittsburg, USA
Yueh-Ming Loo, PhD, Gaithersberg, USA
Naeha Subramanian, PhD, Seattle, USA
Steven F. Ziegler, PhD, Seattle, USA
Reneé C. Ireton, PhD, Seattle, USA
International Advisory Committee:
Simon Jones, PhD, Cardiff, UK
Eleanor Fish, PhD, FAAS, Toronto, Canada
Kate Fitzgerald, PhD, Worcester, USA
Georg Schett, MD, Erlangen, Germany
Akinori Takaoka, MD, PhD, Sapporo, Japan
You-Me Kim, PhD, Pohang, South Korea
At this time we invite you to view the online interactive program of Cytokines 2019 in Vienna, 20-23 October, 2019:
The International Cytokine & Interferon Society (ICIS), is a non-profit organization of over 950 scientists devoted to research in the fields of cytokine, interferon and chemokine cell biology, molecular biology, biochemistry and the clinical use of these biological response modifiers. Bringing together scientists across many different research disciplines, ICIS is the premier organization promoting the field of cytokine biology, impacting all aspects of medicine and leading to new treatments in autoimmune diseases, cancer, infectious diseases and inflammation.
It is a major goal of the ICIS to facilitate interactions between young investigators and trainees with established researchers in the interferon and cytokine field. Outstanding junior investigators, postdoctoral researchers, and graduate/medical students are encouraged to participate in the Annual Scientific meeting through the presentation of prestigious travel awards dedicated to young researchers.